Financhill
Back

Intra-Cellular Therapies Vs. Viking Therapeutics Industry Stock Comparison

Sell
19

ITCI
Intra-Cellular Therapies

Last Price:
73.53
Seasonality Move:
7.83%
Sell
47

VKTX
Viking Therapeutics

Last Price:
54.13
Seasonality Move:
8.99%
Sell
19
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $73.52. The Score for ITCI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $54.16. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $73.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $54.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 46.1 Sell
Chaikin Money Flow: -514822 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.04 - 76.28) Sell
Bollinger Bands (100): (68.13 - 76.69) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 40.93 Sell
Chaikin Money Flow: 868119 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.37 - 63.73) Sell
Bollinger Bands (100): (52.14 - 69.1) Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.98 Buy
20-day SMA: 74.25 Sell
50-day SMA: 75.03 Sell
200-day SMA: 69.81 Buy
8-day EMA: 73.25 Buy
20-day EMA: 74.11 Sell
50-day EMA: 74.13 Sell
200-day EMA: 69.38 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.42 Sell
20-day SMA: 60.55 Sell
50-day SMA: 56.97 Sell
200-day SMA: 50.23 Buy
8-day EMA: 58.53 Sell
20-day EMA: 59.39 Sell
50-day EMA: 58.62 Sell
200-day EMA: 50.21 Buy

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.59 per share.

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):